(1)
Thaci, D.; Gottlieb, A.; Reich, K.; Bagel, J.; Burge, D.; Peterson, L.; Drew, J.; Arendt, C.; Weglowska, J. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). J of Skin 2017, 1, s4.